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Treatment of mice with heat-killed (HK) Mycobacterium bovis BCG or 1- to 10-m chitin particles (nonanti-
genic N-acetyl-D-glucosamine polymers) is known to induce innate immune responses, including gamma in-
terferon (IFN-) production, which plays a Th1 adjuvant role. However, HK BCG further induces prostaglan-
din E2-releasing spleen macrophages (M) (PGE2-M), which potentially inhibit Th1 adjuvant activities. We
found that chitin particles did not induce PGE2-M formation. To further assess whether chitin has Th1
adjuvant effects, interleukin-10 (IL-10)-knockout (KO) mice and their wild-type (WT, C57BL/6) controls were
immunized with a 30-kDa MPB-59 mycobacterial protein mixed with chitin. Immunization with MPB-59 alone
induced Th2 responses, characterized by increases in total serum immunoglobulin E (IgE) and specific serum
IgG1 levels and spleen Th2 cells producing IL-4, IL-5, and IL-10. No IFN--producing spleen Th1 cells, specific
serum IgG2a, or delayed-type hypersentivity (DTH) footpad reactions were detected. On the other hand,
chitin–MPB-59 immunization significantly increased spleen Th1 responses, DTH reaction, and serum IgG2a
levels along with decreases of Th2 responses. The magnitude of these Th1 adjuvant effects was greater in
IL-10-KO mice than in WT mice. In contrast, immunization with HK BCG–MPB-59 showed little or no Th1
adjuvant effect. These data indicate that chitin has a unique Th1 adjuvant effect on the development of Th1
immunity against a mycobacterial antigen. IL-10 down-regulates the adjuvant effect of chitin.
To develop protective immunity against intracellular in-
fections such as tuberculosis, Th1 adjuvants play an impor-
tant role. Live Mycobacterium bovis Calmette-Guerin bacillus
(BCG) and Freund’s complete adjuvant (FCA; heat-killed [HK]
M. tuberculosis in mineral oil) have been used as Th1 adjuvants
in experimental animals (15, 22, 52). Relatively high doses of
HK BCG in saline compared with those of live BCG or FCA
are required for the induction of nonspecific (innate) immune
responses (26). However, HK BCG at high doses also induces
prostaglandin E2 (PGE2)-releasing “suppressor” macrophages
(M) (13, 30, 36). PGE2 differentially modulates Th1 and Th2
immune responses. PGE2 strongly inhibits the production of
Th1 cytokines, such as interleukin-2 (IL-2), IL-12, and gamma
interferon (IFN-), and, PGE2, depending on stimulatory con-
ditions, either has no effect or enhances production of the
Th2-associated cytokines, such as IL-4, IL-5, and IL-10 (6, 16,
45, 47). Therefore, PGE2-M appear to reduce Th1 adjuvant
effects (14).
Recently, we have observed that M phagocytose HK BCG
and HK Propionibacterium parvum (Corynebacterium parvum)
through mannose receptors that recognize carbohydrates of
cell walls, including N-acetyl-D-glucosamine, and produce Th1
cytokines, such as IL-12, IL-18, and tumor necrosis factor 
(TNF-) (38–40). To further study this mechanism, we have
designed 1- to 10-m N-acetyl-D-glucosamine polymer (chitin)
particles that induce M to produce the cytokines at levels
comparable to those stimulated by HK BCG or HK C. parvum
(38, 39). However, unlike HK BCG or HK C. parvum, chitin
particles do not induce PGE2-M formation (this study).
These observations suggest that chitin is a better Th1 adjuvant
than HK BCG.
In this study, to determine Th1 adjuvant effects of chitin, we
have examined whether soluble MPB-59 antigen mixed with
chitin promotes Th1 immunity specific for MPB-59. MPB-59 is
one of the 30-kDa mycobacterial antigens that are produced by
proliferative BCG and M. tuberculosis and are predominant
immunogens (21, 33, 35, 42, 49). When mice develop Th1 im-
munity against these antigens, they resist bacterial challenges
(1, 20, 23, 32, 35). However, immunization with soluble MPB-
59 alone resulted in typical Th2 responses including increases
in specific serum immunoglobulin E (IgE) and splenic Th2
cells producing IL-4, IL-5, and IL-10. In this study, we present
the results of the treatment with chitin as a Th1 adjuvant
compared with those of the treatments with FCA or HK BCG
suspended in saline.
Since it is established that endogenous IL-10 down-regulates
various immune responses, including Th1 and Th2 responses
(11, 18, 25, 28), we also employed IL-10-knockout (KO) mice,
which were expected to provide a significantly higher magni-
tude of the chitin adjuvant effects.
MATERIALS AND METHODS
Mice. Breeding pairs of IL-10-KO (C57BL/6-II10tm1Cgn) mice (28) were ob-
tained from the Jackson Laboratory (Bar Harbor, Maine). Offspring were raised
under pathogen-free conditions. No mice used in this study showed colitis (39).
Nonpregnant females, 8 to 14 weeks old, were used for experiments. Age-
matched female C57BL/6 mice were obtained from the Jackson Laboratory and
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used as wild-type (WT) control mice. Both IL-10-KO and WT mice were main-
tained in barrier-filtered cages and fed Purina laboratory chow and tap water ad
libitum. Experimental protocols employed in this study were approved by
IACUC of East Carolina University Brody School of Medicine.
Preparations of chitin particles and HK BCG. As described previously (38,
40), chitin particles (1 to 10 m) were prepared from purified chitin powders
(Sigma Chemical Co., St. Louis, Mo.), suspended in saline (20 mg/ml), auto-
claved, and stored at 4°C until use. The cultured bacteria of M. bovis BCG Tokyo
172 strain (the Japanese vaccine) were washed, autoclaved, and lyophilized. The
powder of HK BCG was suspended in saline immediately before use. The
suspensions of both chitin and HK BCG were dispersed by brief sonication (10
s) prior to injection. These chitin and HK BCG preparations contained unde-
tectable levels of endotoxin (0.03 endotoxin units/ml), as determined by the
Limulus amebocyte lysate assay (Sigma) (39). Similarly, HK C. parvum suspen-
sions were prepared as previously described (36).
Purified MPB-59. MPB-59 (30 kDa) was prepared from culture filtrates of
M. bovis BCG Tokyo 172 as described previously (19). The bacteria were cul-
tured in Sauton synthetic medium at 37°C without aeration for 8 days. Sixty liters
of culture filtrates was concentrated with ultrafiltration with a Pellicon Cassette
system (XX42PEL60; Millipore, Bedford, Mass.) with a molecular weight 5,000
cutoff membrane (YM-3; Amicon, Beverly, Mass.). Proteins were further con-
centrated with 60% saturated ammonium sulfate and fractionated high-pressure
liquid chromatography (i) affinity chromatography with phenyl Sepharose CL-
4B, (ii) DEAE Sepharose CL-6B ion exchange, (iii) Sephacryl S200 HR gel
filtration, and (iv) re-ion-exchange with DEAE Sepharose CL-6B (all from Phar-
macia LKB, Uppsala, Sweden) (19). Following sodium dodecyl sulfate-polyac-
rylamide gel electrophoresis analysis with 10 g of purified MPB-59 protein, a
single 30-kDa band was stained by silver (data not shown). The procedure
resulted in 4 mg of purified MPB-59 from 60 liters of culture filtrates.
Endotoxin removal. Endotoxin removal from all soluble materials for cultures
and administration to mice were carried out by filtration and sterilization through
0.22-m-pore-size Zetapore membranes (AMF-Cuno). The effectiveness of en-
dotoxin removal was monitored by the Limulus amebocyte assay (Sigma).
Mouse immunization protocol and footpad DTH. Groups of mice (six/group)
were given MPB-59 and/or chitin four times intraperitoneally at weekly intervals
as follows: group I, MPB-59 (50 g/dose) alone; group II, 1- to 10-m chitin (200
g/dose) alone; group III, mixtures of MPB-59 (50 g/dose) and chitin (200
g/dose); and group IV, saline (0.1 ml/dose) as controls. In some experiments, to
determine whether HK BCG in saline at a dose that induces innate immune
responses (Fig. 1B) has a Th1 adjuvant effect, we employed HK BCG (200
g/dose) instead of chitin. Seven days after the final immunization, footpad
delayed-type hypersensitivity (DTH) reactions to the locally injected MPB-59
were assessed. Mice received 50 l of MPB-59 solution at 1,000 g/ml in the right
footpad and saline in the left footpad (control). After 48 h, mice were euthanized
and MPB-59-induced footpad swelling was monitored with a spring-loaded met-
ric caliper (Mitutoyo, Kawasaki, Japan). Spleens and blood were also harvested.
As a positive Th1 adjuvant control, 1 ml of saline with 500 g of MPB-59 was
mixed with 1 ml of FCA, and the mixture was given intraperitoneally to a group
of mice (0.2 ml/dose) on days 0 and 14. Fourteen days after the final immuni-
zation, footpad DTH reactions were measured as described above.
Cytokine production in recall response—spleen cell cultures stimulated with
MPB-59 antigen. Spleens in each group of mice were isolated and pooled. Spleen
cells (4  106 cells/ml) were suspended in RPMI 1640 plus 10% fetal bovine
serum and incubated with MPB-59 at 10, 20, and 50 g/ml for 4 days. After the
incubation, the culture supernatants were collected, and the levels of selected
cytokines (IL-4, IL-5, IL-10, and IFN-) were measured by the appropriate
specific enzyme-linked immunosorbent assay (ELISA) with commercially avail-
able reagents (PharMingen [San Diego, Calif.] and Endogen).
PGE2-M. Plastic-adherent spleen M were prepared as described before
(36, 37) and cultured in serum-free RPMI 1640 medium with or without calcium
ionophore A23187 at 106 M for 2 h. PGE2 levels in the culture supernatants
were measured by a competitive ELISA (Cayman, Ann Arbor, Mich.).
Levels of IgE, IgG1, and IgG2a specific for MPB-59 in serum. Total serum IgE
levels were detected by ELISA using purified mouse IgE 	 isotype (PharMingen)
as a standard and rat anti-mouse IgE monoclonal antibody, clone R35–72
(PharMingen), as a capture antibody. Levels of MPB-59-specific IgE, IgG1, and
IgG2a were measured by ELISA with 96-well plates that were coated with
MPB-59 at 0.3 g/0.1 ml/well in 0.05 M sodium carbonate buffer, pH 9.6,
overnight at 4°C. Biotinylated rat monoclonal antibodies detecting IgE, IgG1,
and IgG2a were clones R35-92, A85-1, and R19-15, respectively (PharMingen).
Superoxide anion release assay. Superoxide anion levels released by alveolar
M were measured by a cytochrome c reduction assay as described previously
(38, 39). Plastic-adherent alveolar M were placed in HEPES-bicarbonate buffer
containing 50 M ferricytochrome c (Sigma) and incubated at 37°C for 1 h in the
presence of phorbol myristate acetate (1 M). The amount of reduced ferri-
cytochrome c was measured by using a molecular extinction coefficient of 21.1
mM1 cm1 from the change in absorbance at 550 nm against a cell-free blank.
Superoxide formation was expressed as nanomoles per 106 cells.
Statistics. Data from this project were analyzed by one-way analysis of vari-
ance. For culture studies, tissues isolated from at least four mice were pooled;
their cells were cultured in at least triplicate in each group. A P value of less than
0.05 is considered statistically significant.
RESULTS
Chitin induced alveolar M priming but not splenic PGE2-
M formation. Results comparable to those in Fig. 1A have
FIG. 1. Alveolar M priming and the formation of PGE2-M in
the spleen following HK BCG administration. WT and IL-10-KO mice
intravenously received 0.5 mg of HK BCG, chitin, or HK C. parvum
(CP; positive control). Mice that received 0.2 ml of saline served as
negative controls. Furthermore, some groups received chitin (0.5 mg)
mixed with HK BCG (0.5 mg) or HK C. parvum (0.5 mg). (A) Super-
oxide anion release by alveolar M. On day 3, alveolar M were
assayed in vitro for superoxide anion release by phorbol myristate
acetate (1 M). Superoxide anion levels were measured by a cyto-
chrome c reduction assay as described in Materials and Methods. Data
are means plus standard deviation; n 
 4. , P  0.05 compared with
chitin alone; , P  0.01 compared with BCG alone or C. parvum
alone. (B) PGE2 release by spleen M. On day 7, splenic M were
isolated from the other set of experimental groups. M in each group
were pooled and incubated in serum-free RPMI 1640 medium con-
taining A23187 at 106 M for 2 h. The levels of PGE2 were measured
by ELISA. Values are means plus standard deviations; n 
 3. , P 
0.01 compared with BCG alone or C. parvum alone.
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been reported earlier; the present observations are included
because they validate assumptions necessary for interpretation
of the present findings. Previous studies (38, 39) demonstrated
that intravenous injection of bacteria or chitin results in the
priming of alveolar M, involving the mechanisms of NK cell
production of IFN-. To confirm whether HK BCG or chitin
induces the priming of alveolar M, WT and IL-10-KO mice
were given 0.5 mg of HK BCG, HK C. parvum (a positive
control), or chitin intravenously. We isolated alveolar M from
the groups and measured superoxide anion levels released by
the M. We found that HK BCG, HK C. parvum, and chitin
induced alveolar M priming at comparable levels on day 3
(Fig. 1A) but not on day 7 (data not shown). Furthermore,
alveolar M on day 3 from mice receiving the chitin–HK-BCG
or chitin–HK-C. parvum mixture slightly increased superoxide
anion release (Fig. 1A). We also confirmed that endogenous
IL-10 inhibited alveolar M priming levels (39).
To assess whether these treatments result in the formation
of PGE2-M in the spleen (36, 37), splenic M were isolated
on day 7 and stimulated in vitro with A23187 at 106 M for 2 h.
As shown in Fig. 1B, PGE2 levels were unchanged in saline
control and chitin-treated groups, whereas significantly higher
levels of PGE2 were observed in both HK-BCG- and HK-
C. parvum-treated groups. IL-10-KO mice showed more PGE2
than WT mice, suggesting that endogenous IL-10 inhibits
splenic PGE2-M formation. The PGE2 production in vitro
was over 90% inhibited by nimesulide, a PGG/H synthase-2
inhibitor, at 1 M (data not shown). Interestingly, the group
treated with the mixture of HK BCG with chitin (0.5 mg each)
showed lower levels of PGE2 than the group receiving HK
BCG alone. As reported previously (36), splenic M on day 3,
however, showed no detectable increase in PGE2 levels in all
groups (data not shown). Similar kinetics of PGE2-M forma-
tion were observed when HK BCG or HK C. parvum was given
intraperitoneally and subcutaneously (data not shown).
Recall responses of spleen cell cultures from mice coimmu-
nized with MPB-59 and chitin. To determine whether MPB-
59-induced Th2 cell development was modulated by coinjected
FIG. 2. Chitin-treated mouse spleen cells decreased MPB-59-stimulated IL-4, IL-5, and IL-10 production but increased MPB-59-stimulated
IFN- production. Spleen cells were isolated from the WT mouse groups receiving the indicated treatment and stimulated in vitro with MPB-59
at 0 (medium), 10, 20, and 50 g/ml for 4 days. The cytokine levels in the culture supernatants were measured by ELISA, as described in Materials
and Methods. Values are means plus standard deviation from triplicate cultures. The data shown are representative of two independent
experiments. , , and , P  0.05, P  0.01, and P  0.005 compared to the MPB-59-immunized group.
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chitin, selected cytokine levels produced by Th1 and Th2 cells
were measured in recall responses of spleen cell cultures.
When spleen cells were prepared from MPB-59-immunized
WT mice and stimulated in vitro by MPB-59 at 10, 20, and 50
g/ml, relatively large amounts of IL-4, IL-5, and IL-10, but
not IFN-, were detected (Fig. 2). When mice were coimmu-
nized with chitin and MPB-59, the levels of IL-4, IL-5, and IL-
10 were significantly reduced (Fig. 2A to C). In contrast, IFN-
production was significantly increased (Fig. 2D). However,
there was little or no production of these cytokines when spleen
cells were prepared from saline- or chitin-treated WT control
mice and stimulated in vitro by MPB-59 antigen (Fig. 2).
To determine whether endogenous IL-10, which is produced
by diverse cell populations, including antigen-stimulated Th2
cells (28), down-regulates Th1 or Th2 responses, we immu-
nized IL-10-KO mice with MPB-59 mixed with chitin. As shown
in Fig. 3, IL-4 and IL-5 production was higher in the recall
responses of MPB-59-immunized IL-10-KO mice than in those
of MPB-59-immunized WT mice (Fig. 2A and B). When IL-
10-KO mice were coimmunized with MPB-59–chitin, higher
levels of IFN- were observed along with marked reduction of
IL-4 and IL-5 production (Fig. 3). The results support the
previous observations that IL-10 down-regulated both antigen-
specific Th1 and Th2 responses (11, 18, 25, 29).
Serum IgG1, IgG2a, and IgE levels in mice coimmunized
with MPB-59 and chitin. We observed that immunization of
WT mice with MPB-59 resulted in increases in levels of total
IgE and MPB-59-specific IgG1 in serum (Fig. 4A and C). Since
endogenous IL-4 and IFN- isotype-switching signals antigen-
specific B cells, which bias the serum IgE and IgG1 and the
serum IgG2a, respectively (8, 44), we determined if these
heavy-chain class switches are developed by coimmunization of
MPB-59 and chitin. As shown in Fig. 4D, there was a relatively
low level of serum IgG2a. In contrast, after coimmunization
with MPB-59 and chitin, the levels of IgG1 and IgE were
significantly reduced (Fig. 4A and C). Interestingly, MPB-59-
immunized IL-10-KO mice showed a significant enhancement
of total IgE, MPB-59-specific IgE, and MPB-59-specific IgG1
levels compared with those in WT mice; following immuniza-
tion with MPB-59 and chitin, IgG2a levels were also signifi-
cantly enhanced (Fig. 4).
Our results suggest that MPB-59 is a strong allergen which
induces IL-4-dependent IgG1 and IgE production (8). Chitin-
induced endogenous IFN- appears to regulate antibody heavy-
chain class switching, resulting in higher IgG2a levels (44).
Furthermore, endogenous IL-10 appears to down-regulate IL-
4-dependent IgG1 and IgE production and IFN--dependent
IgG2a production.
Footpad DTH reaction in mice coimmunized with MPB-59
and chitin. To determine if chitin has adjuvant effects to de-
velop DTH reactions, mice were immunized with MPB-59
mixed with chitin. As shown in Fig. 5, 2 days after the challenge
with MPB-59 in the footpad, the thickness of the footpads was
measured. Both WT and IL-10-KO mice showed significant
footpad thickness following the challenge. Although the foot-
pad reactions seemed to be stronger in IL-10-KO than in WT
mice, there was no statistically significance between MPB-59–
chitin-immunized IL-10-KO and WT mice (Fig. 5).
Does coinjected HK BCG provide a Th1 adjuvant effect?
To determine whether HK BCG has a Th1 adjuvant effect,
FIG. 3. Chitin-treated mouse spleen cells decreased MPB-59-stim-
ulated IL-4 and IL-5 production but increased MPB-59-stimulated
IFN- production in IL-10-KO mice. IL-10-KO mice were immunized
as described in Materials and Methods. Recall responses of spleen cell
cultures were assayed as described in the Fig. 1 legend. Values are
means plus standard deviations from triplicate cultures. The data
shown are representative of two independent experiments. , , and
, P  0.05, P  0.01, and P  0.005 compared to the MPB-59-
immunized group.
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C57BL/6 (WT) mice (six per group) were immunized with
MPB-59 mixed with HK BCG (200 g/dose) in saline at sched-
ules and in groups similar to those receiving coinjected chitin.
As a positive Th1 adjuvant, additional mice were immunized
with MPB-59 mixed with FCA.
Figure 6 summarizes the IL-4 and IFN- levels in recall
responses of spleen cell cultures, MPB-59-specific serum IgE
and IgG2a, and footpad DTH reactions. MPB-59 in FCA en-
hanced footpad DTH reactions and antigen-specific IgG2a lev-
els and reduced IgE levels. This Th2-to-Th1 shift was associ-
ated with relatively high IFN- levels and low IL-4 levels in
recall responses. In contrast, mice immunized with MPB-59
mixed with HK BCG in saline showed neither up-regulation of
Th1 responses nor down-regulation of Th2 responses specific
for MPB-59.
DISCUSSION
Previously, we observed that phagocytosable nonantigenic
chitin, a seemingly inert molecule, as well as HK BCG and HK
C. parvum, induced endogenous Th1 cytokines (IL-12, IL-18,
TNF-, and IFN-) (38–40). These cytokines are generally
seen at early stages of infection (innate immunity) caused by
mycobacteria and other intracellular bacteria (39). Innate im-
munity is important for protection against intracellular bacte-
rial infections and to induce Th1 responses and cell-mediated
immunity against bacteria (2). It is well established that Th1
cytokines down-regulate allergic immune (Th2) responses
(34). Consistent with our previous study (41), the present study
clearly demonstrated that chitin, as a Th1 adjuvant, down-
regulates antigen-specific Th2 responses and up-regulates Th1
responses specific for a mycobacterial antigen.
The provocative findings are that MPB-59 induces Th2-
dominant immune responses, including those of IL-4-, IL-5-,
and IL-10-producing splenic Th2 cells, and increases in total
serum IgE and MPB-59-specific IgG1 levels. Increases in these
inflammatory parameters have been demonstrated in typical
airway allergic responses (41). In this study, we found that
MPB-59 immunization did not establish DTH reactions. In
FIG. 4. Chitin treatment modulated total IgE levels and MPB-59-
specific-antibody formation (IgE, IgG1, and IgG2a) in WT and IL-
10-KO mice. Sera were isolated from WT and IL-10-KO mice that
were immunized with MPB-59, MPB-59–chitin, chitin, and saline as
described in Materials and Methods. (A) Total IgE levels in the sera
were measured by a sandwich ELISA. Values are means plus standard
deviations; n 
 6. (B through D) MPB-59-specific IgE, IgG1, and
IgG2a in sera were quantitated as described in Materials and Methods.
The sera were diluted 1/5, 1/100, and 1/20 with saline before they were
assayed for MPB-59-specific IgE, IgG1, and IgG2a levels, respectively.
Values are mean plus standard deviations; n 
 6. , , and , P 
0.05, P  0.01, and P  0.005 compared to the MPB-59-immunized
group.
FIG. 5. Development of MPB-59-induced footpad DTH in WT and
IL-10-KO mice coimmunized with MPB-59 and chitin. WT and IL-
10-KO mice were immunized with MPB-59, MPB-59–chitin, chitin,
and saline as described in Materials and Methods. Seven days after the
final immunization, mice received 50 g of MPB-59 solution in the
right footpad and 50 l of saline in the left footpad (control). After
48 h, right footpad thickness minus left footpad thickness in each
group of mice was calculated. Values are means plus standard devia-
tions; n 
 6.  and , P  0.05 and P  0.01 compared to the
MPB-59-immunized group.
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contrast, when mice were immunized with MPB-59 mixed with
chitin, chitin down-regulated these Th2-dominant responses
and up-regulated IFN--producing Th1 cells. This increase in
IFN- levels is associated with an increase in MPB-59-specific
IgG2a levels that illustrates isotype switching by B cells (44).
Under these Th1-dominant conditions, MPB-59 induces lo-
cal DTH responses. It has been reported that DTH is IFN-
dependent but requires additional factors such as IL-8, TNF-,
and migration inhibitory factor produced by M and activated
T cells (5, 9).
It is particularly important that HK BCG at a dose that
induced innate immune responses including IFN- production
did not down-regulate Th2 responses or up-regulate Th1 re-
sponses in the MPB-59 immunization model (Fig. 6). Previous
studies showed that BCG immunotherapies in cancer induce
suppressor T cells and suppressor M (3, 13, 30) that reduce
protective immunity against tuberculosis and cancer. Recent
studies suggest that suppressor T cell functions can be, at least
in part, explained by development of mycobacterium-specific
Th2 cells (25, 46, 51, 54). Suppressor M that release PGE2
would be associated with this shift of Th1-to-Th2 response (14,
16, 45, 47). It is of particular importance that effective Th1
adjuvants should not induce but inhibit the formation of PGE2-
M (14), although the mechanisms of chitin treatments that
inhibit PGE2-M formation (Fig. 1) remain to be elucidated.
It should be noted that HK BCG in light mineral oil, HK
Listeria monocytogenes in Freund’s incomplete adjuvant, and
HK M. tuberculosis in mineral oil (FCA) have been used ex-
FIG. 6. Immunity against MPB-59 when mice were immunized with MPB-59 mixed with HK BCG in saline or mixed with FCA. C57BL/6 mice
were immunized with MPB-59, MPB-59 in FCA, MPB-59 mixed with HK BCG in saline, HK BCG, and saline as described in Materials and
Methods. (A and B) IL-4 and IFN- levels produced in recall responses of spleen cell cultures, respectively. Spleen cells were isolated from each
group of mice stimulated in vitro with MPB-59 at 20 g/ml for 4 days. The levels of IL-4 and IFN- in the culture supernatants were measured
by ELISA, as described in Materials and Methods. Values are means plus standard deviations from triplicate cultures. (C and D) MPB-59-specific
IgE and IgG2a titers, respectively, in serum. Immediately after footpad thickness measurements, sera were isolated from all groups of mice.
MPB-59-specific IgE and IgG2a in sera were quantitated as described in Materials and Methods. Values are means plus standard deviations; n 

6. (E) DTH reaction (footpad thickness). Seven days after the final immunization (14 days after the second injection of MPB-59 in FCA), mice
received 50 g of MPB-59 solution in right footpad and 50 l of saline in left footpad (control). After 48 h, right footpad thickness minus left
footpad thickness in each group of mice was calculated. Values are means plus standard deviations; n 
 6. The data are representative of two
independent experiments. , , and , P  0.05; P  0.005, and P  0.0005 compared to the MPB-59-immunized group.
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tensively for the enhancement of cell-mediated immunity
against coinjected antigens (17, 53). The present study showed
that FCA induces Th1 responses specific for coinjected MPB-
59 (Fig. 6). However, cell walls isolated from BCG, M. tuber-
culosis, and C. parvum appear to contain essential components
for the induction of splenic PGE2-M formation (13). FCA at
the dose used in this study (0.01 mg of HK M. tuberculosis/
dose) did not induce PGE2-M, while HK BCG at 0.1 mg/
dose in either saline or mineral oil induced PGE2-M (13).
Therefore, the adjuvant effects of HK BCG at various concen-
trations suspended in mineral oil or in saline remain to be
elucidated (26, 47).
Observations in our earlier (39) and present studies showed
that antigen-stimulated Th2 cells, chitin-stimulated M, and
HK-BCG-stimulated M produce IL-10. In addition, many
other diverse cell populations, including bronchial epithelial
cells and B cells, produce IL-10 (7, 29). Endogenous IL-10 is a
powerful negative regulator for chitin- or HK-BCG-induced
innate immune responses characterized by the production of
IL-12, IL-18, TNF-, and IFN- (39). IL-10 also inhibits pro-
tective immunity against intracellular bacterial infections due
to the down-regulation of IFN- production (4, 11, 12). It has
also been reported that IL-10 inhibits Th2 responses to aller-
gens, most likely by inhibiting antigen-presenting cells (11, 18,
25, 39). The present study confirms that immunization of IL-
10-KO mice with MPB-59 induces significantly higher levels of
serum IgE- and IgG1-producing and IL-4- and IL-5-producing
Th2 cells than MPB-59 immunization of WT controls. Further-
more, chitin as a Th1 adjuvant induces MPB-59-specific Th-1
cells, footpad DTH, and serum IgG2a in IL-10-KO mice. Our
studies clearly support the conclusion that endogenous IL-10
down-regulates the development of antigen-specific Th1 and
Th2 responses rather than inducing the shift of Th1 to Th2
responses.
It has been established that several other bacteria and their
components (24, 31, 40, 43, 48, 50, 53), such as lipopolysac-
charide, superantigens, and DNA with unmethylated CpG
motifs, induce Th1 cytokines that up-regulate Th1 responses
with down-regulation of Th2 responses. Their efficacy in reg-
ulating immune responses is limited by some toxic side effects,
including splenomegaly (10, 27) as well as the formation of
PGE2-M in the spleen. The chitin treatments in this study
accomplished significant modification without any visible ad-
verse effects, splenomegaly (data not shown), or splenic PGE2-
M formation. As a result, chitin preparations of nonmicrobial
origin represent a very attractive new class of Th1 adjuvant.
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